The European Food Safety Authority (EFSA) has indicated that stimulation of protective antibody titers from vaccination could be used to substantiate a supplement or food health claim on the function of the immune system related to defense against pathogens in healthy 
Background
Probiotic supplements are purported to prevent infectious illness and enhance health.
Initially recognized to reduce symptoms of gastrointestinal illness, in particular antibiotic associated diarrhea and acute infectious diarrhea, the list of illnesses for which probiotics may be beneficial has grown to include oral health, respiratory illness, metabolic dysfunction and some cancers [1] [2] [3] [4] [5] . Probiotics are likely to exert their health effects via a combination of mechanisms, such as competitive displacement of pathogens in the mucosa, the production of antimicrobial proteins that are toxic to pathogens, the production of metabolic substrates for mucosal integrity and the modulation of immune function. While there has been an extensive body of research undertaken, the evidence base for probiotics has been described as uncertain, confusing and conflicting 6, 7 . This has, however, not prevented claims of efficacy being promulgated within the media and for probiotic supplements to enjoy broad popularity.
In order to protect consumers from unsubstantiated claims regarding enhanced immune function, regulatory agencies have indicated the need for immune challenge tests related to improved protection from pathogens. In this context vaccination-induced antibody response has been proposed as the ideal model for determining the effect of probiotic supplementation on immune function. This conflicts with growing evidence that probiotics exert antiinflammatory influence on the immune system 8, 9 . We propose in this mini-review that probiotic upregulation of T-cell dominant immune-regulatory pathways via the induction of FoxP3+ T-regulatory cells (T-regs) optimizes the dynamic balance between suppression and effector mechanisms without compromising respiratory viral host defense. This conflicts with a vaccine model of immune enhancement given that T-regs compromise vaccine efficacy.
Caution regarding the applicability of the vaccine model is warranted in relation to viral respiratory infection.
Probiotics for health
Initial evidence for the benefits of probiotic supplementation was for symptoms associated with gastrointestinal illness. While differential findings are reported between population cohorts and probiotic strains, meta-analyses indicate that probiotics reduce the risk of developing antibiotic associated diarrhea by ~50% and infectious diarrhea by 15-50% along with moderate reductions in severity and duration of illness [10] [11] [12] [13] . Understanding of the role of authochnous bacteria also led to interest in the effects of probiotic supplements for other illnesses, particularly common infectious illness (common cold) in the healthy population. In the generally healthy population consumption of a combination probiotic containing
Lactobacillus plantarum HEAL 9 (DSM 15312) and Lactobacillus paracasei 8700:2 (DSM 13434) reduced the incidence of the common cold by ~20% (P<0.05) and led to a 27% reduction in days of illness (P<0.05) 14 . In two independent studies of 142 elderly individuals (n=57 and 85 respectively) supplementation with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 was associated with a 2.6-fold lower risk of catching a cold 15 . Other studies have shown benefits for respiratory symptoms in athletic cohorts 16 , children 17 and shift workers 18 . However, these effects are not uniform. Gender differences have been noted in one study 19 and in a number of other studies probiotic supplements have had no significant effect on respiratory symptoms 20, 21 . A recent meta-analysis found that while evidence is weak, overall some probiotics have beneficial effects on the incidence, duration and severity of acute respiratory illness 5 .
While various mechanisms are likely to underpin the beneficial effects reported for probiotic supplementation on respiratory illness, it is direct modulation of the immune system that has been the primary focus of research. Human intervention studies have found contradictory effects depending on strain and dosage of bacteria, duration of 6 supplementation, outcome markers and cohort under investigation. Overall the effect of probiotics in-vivo can only be described as modest at best. Berggren et al 14 23 . However, when correlated with the recovery of BB-12 in feces the production of whole blood interferon-γ was significantly reduced in the probiotic group. Overall these data indicate that probiotic supplementation has little effect on the immune system of healthy individuals.
Health claims related to immune function
With an increasingly health conscious, informed and connected population there is strong commercial interest in the use of claims for health and immune function to promote probiotic supplements within the general population. Thus far, however, the equivocal results from studies of probiotic supplements have led to an almost outright rejection of commercial applications proposing health and immune claims, particularly by EFSA 24 . In considering future research design EFSA published a Scientific Opinion -Guidance on the scientific 7 requirements for health claims related to gut and immune function 25 . A key issue noted in the paper relates to claims on immune function related to defense against pathogens. The
Guideline notes that immunological parameters measured need to be relevant (to host protection from infection by the pathogen/s of interest) preferably shown in the same intervention study that shows clinical benefit (page 10) 25 . Such advice arguably makes it difficult to measure a small number of discrete parameters of the immune system and argue that observed changes are practically meaningful. However, EFSA note "that stimulation of protective antibody titers (in response to vaccination) could be used to substantiate a health claim on the function of the immune system related to defense against pathogens" 25 . Given that vaccine antibody responses are correlated with protection from pathogen infection, a heightened antibody response observed in conjunction with probiotic supplementation could be considered a beneficial response of supplementation.
Immune suppression and viral infection
A recent animal study leads to questions over the utility of the vaccine model for evidence of probiotic-enhanced immune activity for defense against viral infection. In mice Further complicating the relevance of a vaccination model as a surrogate end-point for probiotic-related enhancement of immunity is that many probiotic supplements exert an antiinflammatory influence on the immune system, particularly the adaptive immune system, and promote iT-regs differentiation from CD4+CD25-T cells ex-vivo and in animal models 30 .
Some probiotic strains also increase the activity of nT-regs cells. In a human peripheral blood
W62 or an Escherichia coli control strain differentially increase T-reg number 31 . In this study Probiotic-induced induction of T-regs also provides a potential model to explain the reduced duration and severity of respiratory illness evident in clinical human studies. The beneficial effects of probiotics in shortening the duration of symptoms has been proposed to be due to their ability to accelerate protective immunity and to subsequently clear pathogens more quickly 6 . Viral infection-induced symptoms are the result of inflammatory mediators, in particular cytokine secretion 35 . Further evidence of this comes from animal studies in which ablation of T-regs results in an increase in effector CD8T-cell frequency and heightened illness symptoms 36 . This suggests that induction of a pro-inflammatory response by probiotics would instead worsen the severity of symptoms and lengthen the duration of 10 illness. In contrast, the findings by Liu et al 26 that T-regs reduce viral illness suggests that the mechanisms for such an effect with daily probiotic supplementation may related to immune suppression rather than enhanced immune activity
The need for evidence that changes in immune function are relevant to defense against infection has led to recommendations by regulatory agencies that vaccine models are a surrogate for evidence of an integrated immune response to challenge. Animal evidence suggests that antigen specific T-cell dominant immune regulatory pathways are associated with reduced respiratory viral symptomatology which does not affect viral clearance.
Probiotics supplements have been shown to exert anti-inflammatory influence on the immune system and induce T-regs. This raises some doubt over the utility of vaccine models for probiotic-induced immune modulation related to viral respiratory infection. Furthermore, it provides a model to explain the beneficial effects of probiotic supplementation on respiratory illness duration and severity.
